Detailed Segmentation-
By Type
(Revenue, USD Bn, 2021 - 2033)- Polysaccharide Vaccines
- Conjugate Vaccines
- Combination Vaccines
- Other
By Sales Channel
(Revenue, USD Bn, 2021 - 2033)- Public
- Private
By Age Group
(Revenue, USD Bn, 2021 - 2033)- Infants (0 to 2 years)
- Children and Adults (2 years & above)
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- North America